HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

zosuquidar trihydrochloride (LY335979)

multidrug resistance modulator; structure in first source
Also Known As:
LY335979; (2R)-anti-5-(3-(4-(10,11-difluoromethanodibenzo-suber-5-yl)piperazin-1-yl)2-hydroxypropoxy)quinoline trihydrochloride; LY 335979; RS 33295-198; RS-33295-198
Networked: 16 relevant articles (1 outcomes, 5 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Burgess, Michael: 4 articles (04/2007 - 12/2002)
2. Chaudhary, Ajai: 2 articles (05/2004 - 12/2002)
3. Green, Lisa: 2 articles (05/2004 - 12/2002)
4. Jordan, Christopher: 2 articles (05/2004 - 12/2002)
5. Marder, Phil: 2 articles (05/2004 - 12/2002)
6. Pouliquen, Isabelle: 2 articles (05/2004 - 12/2002)
7. Slapak, Christopher A: 2 articles (05/2004 - 12/2002)
8. Fujita, Takuya: 1 article (03/2021)
9. Kawahara, Iichiro: 1 article (03/2021)
10. Kono, Yusuke: 1 article (03/2021)

Related Diseases

1. Leukemia
2. Sarcoma (Soft Tissue Sarcoma)
3. Neoplasms (Cancer)
4. Breast Neoplasms (Breast Cancer)
5. Non-Hodgkin Lymphoma (Lymphosarcoma)

Related Drugs and Biologics

1. Doxorubicin (Adriamycin)
2. Vincristine (Oncovin)
3. Member 1 Subfamily B ATP Binding Cassette Transporter
4. zosuquidar trihydrochloride (LY335979)
5. Proteins (Proteins, Gene)
6. Multidrug Resistance-Associated Proteins
7. ATP-Binding Cassette Transporters (ABC Transporters)
8. Docetaxel (Taxotere)
9. multidrug resistance-associated protein 1
10. Paclitaxel (Taxol)

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. VAP-cyclo protocol